Volume 5, Emitir 1 (2015)
Metodologia da Trilha Clínica
Application of biomarkers in oncology clinical trials
Naveen Dakappagari, Hua Gong, Reinhold Pollner, Amara Siva, Shabnam Tangri & Jelveh Lameh
Avaliação de Medicamentos
Review of tofacitinib in rheumatoid arthritis
Maria A Lopez-Olivo, Huifang Lu & Jean H Tayar
Artigo de Revisão
Angiokinase inhibitors in non-small-cell lung cancer
Wei-Chen Lu, Chia-Chi Lin, & James Chih-Hsin Yang
Perspectiva
Challenges of combining cytotoxic chemotherapy and tyrosine kinase inhibitors
Michael P Chu, Vijaya L Damaraju & Michael B Sawyer
Resultados da Trilha Clínica
Chemotherapeutic treatment of acute myeloid leukemia: incorporating the results of recent clinical trials
Ali J Mahdi, Eamon J Mahdi & Steven Knapper
Resultados da Trilha Clínica
Cancer therapy with Newcastle disease virus: rationale for new immunotherapeutic combinations
Tamar Plitt & Dmitriy Zamarin
Avaliação de Medicamentos
Clinical rationale of sucroferric oxyhydroxide for controlling hyperphosphatemia in patients with chronic kidney disease
Stuart M Sprague, Morgan Marcuccilli & Viatcheslav Rakov
